EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

ASSESSMENT OF PRESCRIPTION PATTERN OF ANTI- EPILEPTIC DRUGS IN EPILEPSY

Dr. Vishwas A. T. L.*, Dr. Suresha B. S., Dr. Bhanushree D. M., Chetan B., Vinutha M. D., Prashanthi B.

ABSTRACT

Aim: Epilepsy has been considered as a public health problem by world health organization. Antiepileptic drugs (AEDs) are primary therapeutic mode for epilepsy. AED treatment has been demonstrated to control seizure, which decreases morbidity and mortality associated with epilepsy. So the aim of study is to assess the prescription pattern of anti epileptic drugs in epilepsy. Methodology: This is a hospital-based prospective cross-sectional study in which 110 patients were enrolled in this study, following data were collected from patients prescriptions that demographical data, types of epileptic disorder and types of anti epileptic drugs used in patients. Result: We reviewed 110 prescriptions which contained 206 antiepileptic drugs. Males are more 67(60.9%) more using AEDs. Age groups of 40-49 (32.7%) years are more using AEDs. Out of 110 patients 49(44.4%) were suffered from Generalised tonic clonic siezures (GTCS). Over all 71(64.6%) patient got polytherapy and 39 (35.4%) patients got monotherapy. In that Phenytoin (47.6%) was commonly prescribed Antiepileptic drugs. Prescription contains Levetiracetam was only one newer antiepileptic that is 7(3.3%) and older ones are 199(96.7%) of AEDs. Conclusion: Our study concludes that polytherapy is needed to treat epilepsy. Care should be taken while prescribing polytherapy which leads to drug-related problems. Physician plays an important role during selection of AEDs. Clinical pharmacist plays an important role in identifying and reducing the drug therapy related problems. This study concludes that patient education and observation were necessary for proper utilization of drugs.

Keywords: Prescription, Mortality, Pharmacist, Epilepsy.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MARCH ISSUE PUBLISHED

    MARCH 2024 issue has been successfully launched on MARCH 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia